There are probably few words more frightening than those of a doctor telling you "I'm sorry, but I'm afraid you have cancer."

Those words are even more frightening when you're told the cancer you have is one you've never heard of.

You can imagine, then, how tens of thousands of men and women around the world feel each year when they learn they have multiple myeloma.

They are told they have cancer. Multiple myeloma, to be specific. And it's a very, very serious kind of cancer.

What do these men and women do after hearing such news?

Many different things. Each case is unique.

Eventually, though, they all start searching. For information. For answers. For others who are facing the same challenge they are facing.

For hope.

And, all too often, they don't find enough. Enough information. Enough answers. Enough compatriots.

Enough hope.

We want that to change. Now.

So we at Light Knowledge Resources ^[1] are launching The Myeloma Beacon ^[2].

The Myeloma Beacon's goal is to give multiple myeloma sufferers more of what they're looking for.

More information. More answers. More ways to connect with other multiple myeloma sufferers.

And – as much as we can – more hope.

We are just starting on this journey, so we have much to do and much to learn.

Currently, the Myeloma Beacon has a basic, easy-to-navigate design, and a core set of onsite resources and links that we're already quite proud of.

In the next month or two, however, we will be noticeably expanding and deepening the onsite resources and links.

More immediately, we will begin publishing regular news updates related to multiple myeloma.

All of this content – the news items, onsite resources, and even our links directory – will be interactive. Disagree with something we’ve written? Want to add some additional information? Just click on the comment link, and start sharing your thoughts!

The Myeloma Beacon is here to serve you – whether you are a multiple myeloma sufferer, a family member or caregiver of a sufferer, or just someone interested in multiple myeloma. We look forward to your visits at the site and to your feedback and participation.

Welcome!